Wednesday, March 25, 2015 4:54:07 PM
trading on insider information is the worst case, because that means phase 2 has failed, institutions that are selling is another possbility, revalueing risk/benefit in share price before phase 2 results, ...
The IBB is down that affects share price as well, but that cannot be the only reason. BTW the last time the IBB was down that much some months ago, the IBB kept on going down for several days.
I expect the share price to go down to 2.50 till the week before the results come out. Than it is evrything or nothing. I am bullish for the 30 day results but I am afraid for the 90 days results on IS, I fear that one injection with Multistem won't be enough.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM